Unusual Case of Simultaneous Presentation of Plasma Cell Myeloma, Chronic Myelogenous Leukemia, and a Jak2 Positive Myeloproliferative Disorder

por Maerki, J., Katava, G., Siegel, D., Silberberg, J., Bhattacharyya, P. K.
Publicado 2014

Cell-specific activation and detoxification of benzene metabolites in mouse and human bone marrow: identification of target cells and a potential role for modulation of apoptosis i...

por Ross, D, Siegel, D, Schattenberg, D G, Sun, X M, Moran, J L
Publicado 1996

A polymorphism in NAD(P)H:quinone oxidoreductase (NQO1): relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity.

por Ross, D., Traver, R. D., Siegel, D., Kuehl, B. L., Misra, V., Rauth, A. M.
Publicado 1996

A Tumor Growth Inhibition Model Based on M‐Protein Levels in Subjects With Relapsed/Refractory Multiple Myeloma Following Single‐Agent Carfilzomib Use

por Jonsson, F, Ou, Y, Claret, L, Siegel, D, Jagannath, S, Vij, R, Badros, A, Aggarwal, S, Bruno, R
Publicado 2015

Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase).

por Traver, R. D., Siegel, D., Beall, H. D., Phillips, R. M., Gibson, N. W., Franklin, W. A., Ross, D.
Publicado 1997

Endoscopic use of EpiFix—dehydrated Human Amnion/Chorion Membrane (dHACM) allograft in patients with Gastric Leak following Sleeve Gastrectomy

por Sousa, D.O. Nicholas, Dharia, D.O. Rahil, Mehta, D.O. Shilpin, Marshall, D.O. Keith, Siegel, D.O. David
Publicado 2017

Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma

por Siegel, D S, Richardson, P, Dimopoulos, M, Moreau, P, Mitsiades, C, Weber, D, Houp, J, Gause, C, Vuocolo, S, Eid, J, Graef, T, Anderson, K C
Publicado 2014

Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma

por Siegel, D S, Richardson, P, Dimopoulos, M, Moreau, P, Mitsiades, C, Weber, D, Houp, J, Gause, C, Vuocolo, S, Eid, J, Graef, T, Anderson, K C
Publicado 2014

Outcome with lenalidomide plus dexamethasone followed by early autologous stem cell transplantation in patients with newly diagnosed multiple myeloma on the ECOG-ACRIN E4A03 random...

por Biran, N, Jacobus, S, Vesole, D H, Callander, N S, Fonseca, R, Williams, M E, Abonour, R, Katz, M S, Rajkumar, S V, Greipp, P R, Siegel, D S
Publicado 2016

Efficacy and safety of carfilzomib regimens in multiple myeloma patients relapsing after autologous stem cell transplant: ASPIRE and ENDEAVOR outcomes

por Hari, P, Mateos, M-V, Abonour, R, Knop, S, Bensinger, W, Ludwig, H, Song, K, Hajek, R, Moreau, P, Siegel, D S, Feng, S, Obreja, M, Aggarwal, S K, Iskander, K, Goldschmidt, H
Publicado 2017

Carfilzomib–lenalidomide–dexamethasone vs lenalidomide–dexamethasone in relapsed multiple myeloma by previous treatment

por Dimopoulos, M A, Stewart, A K, Masszi, T, Špička, I, Oriol, A, Hájek, R, Rosiñol, L, Siegel, D, Mihaylov, G G, Goranova-Marinova, V, Rajnics, P, Suvorov, A, Niesvizky, R, Jakubowiak, A, San-Miguel, J, Ludwig, H, Ro, S, Aggarwal, S, Moreau, P, Palumbo, A
Publicado 2017

Pomalidomide, bortezomib and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma

por Richardson, P G, Hofmeister, C C, Raje, N S, Siegel, D S, Lonial, S, Laubach, J, Efebera, Y A, Vesole, D H, Nooka, A K, Rosenblatt, J, Doss, D, Zaki, M H, Bensmaine, A, Herring, J, Li, Y, Watkins, L, Chen, M S, Anderson, K C
Publicado 2017

Correction: Pomalidomide, bortezomib, and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma

por Richardson, P. G., Hofmeister, C. C., Raje, N. S., Siegel, D. S., Lonial, S., Laubach, J., Efebera, Y. A., Vesole, D. H., Nooka, A. K., Rosenblatt, J., Doss, D., Zaki, M. H., Bensmaine, A., Herring, J., Li, Y., Watkins, L., Chen, M. S., Anderson, K. C.
Publicado 2018

PB2012: A PHASE 2 MULTIARM STUDY OF MAGROLIMAB COMBINATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

por Paul, B., Liedtke, M., Siegel, D. S., Khouri, J., Hillenglass, J., Rifkin, R., Gandhi, M. D., Kin, A., Levy, M. Y., Mohrbacher, A., Schmidt, W., Silbermann, R., Cottini, F., Sborov, D. W., Walker, R., Murphy, M., Gu, L., Chen, A., Rajakumaraswamy, N., Usmani, S. Z.
Publicado 2022

Treatment outcomes in patients with relapsed and refractory multiple myeloma and high-risk cytogenetics receiving single-agent carfilzomib in the PX-171-003-A1 study

por Jakubowiak, A J, Siegel, D S, Martin, T, Wang, M, Vij, R, Lonial, S, Trudel, S, Kukreti, V, Bahlis, N, Alsina, M, Chanan-Khan, A, Buadi, F, Reu, F J, Somlo, G, Zonder, J, Song, K, Stewart, A K, Stadtmauer, E, Harrison, B L, Wong, A F, Orlowski, R Z, Jagannath, S
Publicado 2013

First measurement of the vector analyzing power in muon capture by polarized muonic $^{3}$He

por Cummings, W J, Behr, J, Bogorad, P, Brash, E J, Cates, G D, Gorelov, A V, Hasinoff, M D, Häusser, O, Hicks, K, Holmes, R, Huang, J C, Kumar, K, Larson, B, Lorenzon, W, McCracken, J L, Michaux, P, Middleton, H, Saettler, E, Siegel, D, Souder, P A, Swenson, D, Tupa, D, Wang, X, Young, A
Publicado 1995